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A bs tr ac t
Background
Idiopathic membranous nephropathy is a major cause of the nephrotic syndrome in 
adults, but its etiologic basis is not fully understood. We investigated the genetic basis 
of biopsy-proven cases of idiopathic membranous nephropathy in a white population.
Methods
We performed independent genomewide association studies of single-nucleotide 
polymorphisms (SNPs) in patients with idiopathic membranous nephropathy from 
three populations of white ancestry (75 French, 146 Dutch, and 335 British patients). 
The patients were compared with racially matched control subjects; population strat-
ification and quality controls were carried out according to standard criteria. Asso-
ciations were calculated by means of a chi-square basic allele test; the threshold for 
significance was adjusted for multiple comparisons (with the Bonferroni method).
Results
In a joint analysis of data from the 556 patients studied (398 men), we identified sig-
nificant alleles at two genomic loci associated with idiopathic membranous nephrop-
athy. Chromosome 2q24 contains the gene encoding M-type phospholipase A2 receptor 
(PLA2R1) (SNP rs4664308, P = 8.6×10−29), previously shown to be the target of an auto-
immune response. Chromosome 6p21 contains the gene encoding HLA complex 
class II HLA-DQ alpha chain 1 (HLA-DQA1) (SNP rs2187668, P = 8.0×10−93). The as-
sociation with HLA-DQA1 was significant in all three populations (P = 1.8×10−9, 
P = 5.6×10−27, and P = 5.2×10−36 in the French, Dutch, and British groups, respectively). 
The odds ratio for idiopathic membranous nephropathy with homozygosity for both 
risk alleles was 78.5 (95% confidence interval, 34.6 to 178.2).
Conclusions
An HLA-DQA1 allele on chromosome 6p21 is most closely associated with idiopathic 
membranous nephropathy in persons of white ancestry. This allele may facilitate an 
autoimmune response against targets such as variants of PLA2R1. Our findings 
suggest a basis for understanding this disease and illuminate how adaptive immu-
nity is regulated by HLA.
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Membranous nephropathy has an incidence of approximately 1 case per 100,000 persons per year,1 and its phe-
notype has been clearly defined on the basis of 
histologic features, making it a good subject for 
genomewide association studies. Recognized as a 
clinicopathological entity in the 1950s,2 membra-
nous nephropathy is the most common diagnosis 
in adults with the nephrotic syndrome. Roughly 
one fourth of the biopsies performed in patients 
with the nephrotic syndrome show membranous 
nephropathy, which is among the glomerulone-
phritides that lead to end-stage renal disease.3-6 
One of its hallmarks is the presence of glomerular 
deposits that typically contain immunoglobulin 
and complement components. Two major antigens, 
both of which are membrane glycoproteins, have 
been identified in human membranous nephrop-
athy. The first is neutral endopeptidase, the allo-
antigen involved in membranous nephropathy in 
neonates whose mothers have a deficiency of this 
enzyme.7 The second is the M-type phospholipase 
A2 receptor (PLA2R1), the first antigen identified 
in adults with idiopathic membranous nephropa-
thy, which is generally considered to be an autoim-
mune disease.8 Furthermore, two autoantibodies 
against aldose reductase (aldo-keto-reductase fam-
ily 1, member 1 [AKR1B1]) and mitochondrial su-
peroxide dismutase 2 (SOD2) were recently dis-
covered to be present in serum and glomeruli 
from patients with idiopathic membranous ne-
phropathy.9 It is not known why these autoanti-
bodies develop.10-13 Familial occurrence of idio-
pathic membranous nephropathy has been noted 
previously, suggesting a genetic contribution to 
the disease.1,14 Identification of risk alleles or ge-
netic alterations would be a key step in gaining a 
better understanding of the disease mechanism 
and thus the potential to develop specific treat-
ments.15 We performed genomewide association 
studies (discovery and independent replication 
studies) using single-nucleotide–polymorphism 
(SNP) technology to identify risk alleles in three 
separate populations of patients with idiopathic 
membranous nephropathy.
Me thods
Patients
Participants were part of three separate national 
cohorts (French, Dutch, and British) comprising 
patients with idiopathic membranous nephropa-
thy who were of self-reported white ancestry. The 
diagnosis of idiopathic membranous nephropathy 
was established by renal biopsy as part of the rou-
tine clinical workup for the investigation of pro-
teinuria.8 The studies were approved by the relevant 
institutional review boards in the three countries 
and were conducted according to the principles 
of the Declaration of Helsinki. Written informed 
consent was obtained from participants in all 
three studies.
Genotyping
Isolation of DNA and genotyping were performed 
with the use of standard procedures. In the French 
study, DNA samples from 75 case patients (58 men) 
and 157 racially matched controls (66 men) were 
genotyped by Centre National de Génotypage, 
Evry, France; these samples were obtained from 
the GN-PROGRESS Study.16 In the Dutch study, 
DNA samples from 146 case patients (109 men) 
were genotyped by University College London 
Genomics at the Institute of Child Health, London, 
and DNA samples from 1832 racially matched 
Dutch controls (906 men) were genotyped by de-
CODE Genetics, Reykjavik, Iceland; these sam-
ples were from the Nijmegen Biomedical Study.17 
In the British study, DNA samples from 335 case 
patients (231 men) and 349 racially matched con-
trols (108 men) were genotyped by deCODE ge-
netics (see the Supplementary Appendix, avail-
able with the full text of this article at NEJM.org).
Genomewide Association Studies
All genotyping data sets underwent the same rig-
orous quality checks both before and after pa-
tients and control subjects were compared. SNPs 
were excluded from the analysis if they were out 
of Hardy–Weinberg equilibrium (P<0.01), had a 
call rate below 90%, or had an allele frequency 
below 1%. All analyses were carried out with the 
use of established procedures (see the Supplemen-
tary Appendix).18-20
Table 1. Characteristics of Patients in the Three Study Cohorts.*
Characteristic French Cohort Dutch Cohort British Cohort
No. of patients 75 146 335
Sex (no.)
Male 58 109 231
Female 17 37 104
Sex ratio (M:F) 3.4:1 2.9:1 2.2:1
Age at diagnosis (yr) 49.8±15.3 51.8±14.2 52.5±13.3
The New England Journal of Medicine 
Downloaded from nejm.org at RADBOUD UNIVERSITEIT NIJMEGEN on December 6, 2012. For personal use only. No other uses without permission. 
 Copyright © 2011 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 364;7 nejm.org february 17, 2011618
statistical analysis
See the Supplementary Appendix for a description 
of the statistical analyses.
R esult s
Study Participants
Characteristics of the participants in the three 
studies are shown in Table 1. The phenotype was 
remarkably similar among the three cohorts of pa-
tients with idiopathic membranous nephropathy, 
with regard to age at diagnosis and sex ratio. Two 
genomic loci appeared to confer a risk of the dis-
ease in these white participants (Tables 2 and 3).
French Study
This genomewide association study, which as-
sessed 315,049 SNPs in 75 French patients with 
idiopathic membranous nephropathy and 157 ra-
cially matched controls, established a significant 
association with an HLA-DQA1 allele on chromo-
some 6 (Fig. 1). The study population appeared to 
be homogeneous (showed no relevant stratifica-
tion) (Fig. 1 in the Supplementary Appendix). 
SNPs rs2187668 within HLA-DQA1, rs9273327, 
and rs9272192 were significantly associated with 
idiopathic membranous nephropathy (P = 1.8×10−9, 
P = 1.7×10−9, and P = 5.9×10−10, respectively) (Fig. 2 
and Table 1 in the Supplementary Appendix). No 
Table 2. Results of Genomewide Association Studies in the Three Study Groups and the Joint Study, According to 
Single-Nucleotide Polymorphism Characteristics.*
Variable Single-Nucleotide Polymorphism Characteristics
Chromosome 6, rs2187668
(HLA-DQA1)
Chromosome 2, rs4664308
(PLA2R1)
French study
Odds ratio (95% CI) 4.48 (2.68–7.50) 1.87 (1.20–2.92)
Minor allele frequency (%)
Patients 31.3 23.3
Controls 9.2 36.3
P value 1.8×10−9 5.1×10−3
Dutch study
Odds ratio (95% CI) 3.76 (2.92–4.86) 2.27 (1.73–2.97)
Minor allele frequency (%)
Patients 37.0 26.0
Controls 13.5 44.4
P value 5.6×10−27 1.0×10−9
British study
Odds ratio (95% CI) 5.33 (4.04–7.02) 2.10 (1.67–2.64)
Minor allele frequency (%)
Patients 41.9 25.3
Controls 11.9 41.6
P value 5.2×10−36 2.1×10−10
Joint study
Odds ratio (95% CI) 4.32 (3.73–5.01) 2.28 (1.96–2.64)
Minor allele frequency (%)
Patients 39.2 25.2
Controls 13.0 43.4
P value 8.0×10−93 8.6×10−29
* The odds ratios are for the alleles most significantly associated with idiopathic membranous nephropathy on chromo-
somes 6 and 2 (risk allele modeled for both single-nucleotide polymorphisms [rs2187668:A, rs4664308:A]). CI denotes 
confidence interval.
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other SNPs showed significant associations (Fig. 
3 in the Supplementary Appendix).
Dutch Study
This genomewide association study, which as-
sessed 282,440 SNPs in 146 Dutch patients with 
idiopathic membranous nephropathy, as compared 
with 1832 racially matched controls, established 
a significant association with an HLA-DQA1 al-
lele on chromosome 6 and a PLA2R1 allele on 
chromosome 2 (Fig. 1). The study population 
showed no relevant stratification (Fig. 4 in the 
Supplementary Appendix). SNP rs2187668 within 
the HLA-DQA1 gene showed a significant asso-
ciation with idiopathic membranous nephropa-
thy (P = 5.6×10−27). Overall, 191 SNPs within the 
extended HLA locus showed significant associa-
tions with the disease (Fig. 5 and Table 2 in the 
Supplementary Appendix). SNP rs4664308 on chro-
mosome 2 located within PLA2R1 was signifi-
cantly associated with idiopathic membranous 
nephropathy (P = 1.0×10−9), and SNPs rs3749117, 
rs3792189, rs3792192, rs6722275, and rs1870102 
at this locus also showed significant associa-
tions (P = 8.0×10−11, P =4.1×10−11, P =1.4×10−10, 
P =3.8×10−10, and P =1.2×10−9, respectively) (Fig. 6 
and Table 4 in the Supplementary Appendix).
British Study
This genomewide association study assessed 
281,009 SNPs in 335 British patients with idiopath-
ic membranous nephropathy, as compared with 
349 racially matched controls, establishing a sig-
nificant association with an HLA-DQA1 allele on 
chromosome 6 and a PLA2R1 allele on chromo-
some 2 (Fig. 1). The study population showed no 
relevant stratification (Fig. 7 in the Supplemen-
tary Appendix). SNP rs2187668 within the HLA-
DQA1 gene was significantly associated with idio-
pathic membranous nephropathy (P = 5.2×10−36). 
Overall, 144 SNPs within the extended HLA locus 
on chromosome 6 showed significant associations 
(Fig. 8 and Table 3 in the Supplementary Appen-
dix). As in the Dutch study, SNP rs4664308, lo-
cated within PLA2R1, was significantly associated 
with the disease (P = 2.1×10−10). SNP rs1870102 also 
showed a significant association (P = 8.2×10−10) 
(Fig. 9 and Table 5 in the Supplementary Appendix).
Joint Genomewide Association Studies
Because all the patients and controls were of 
white ancestry, it was possible to perform an un-
biased joint analysis of all three independent ge-
nomewide association studies (Fig. 10 in the Sup-
plementary Appendix). For the 556 patients with 
idiopathic membranous nephropathy and the 2338 
controls, we examined 242,824 common SNPs 
and found the two most significant associations 
on chromosomes 6 and 2 for SNPs within HLA-
DQA1 and PLA2R1, respectively (Fig. 2, and Ta-
bles 6 through 9 in the Supplementary Appen-
dix). Both associations were independent of sex 
(data not shown). Significant associations were 
observed for SNP rs2187668 within HLA-DQA1 
on chromosome 6 (P = 8.0×10−93) (Fig. 11 and Ta-
ble 9 in the Supplementary Appendix) and SNP 
rs4664308 within PLA2R1 on chromosome 2, 
which was recently identified as a major target 
Table 3. Odds Ratios for Idiopathic Membranous Nephropathy, According to Single-Nucleotide Polymorphism (SNP)
and Genotype Combinations.*
SNP rs2187668 (HLA-DQA1) SNP rs4664308 (PLA2R1)
GG GA AA
GG
No. of cases/total no. of subjects 14/354 79/944 97/659
Odds ratio (95% CI) 1.00 2.22 (1.24–3.97) 4.19 (2.36–7.46)
GA
No. of cases/total no. of subjects 23/115 94/363 178/348
Odds ratio (95% CI) 6.07 (3.01–12.27) 8.49 (4.73–15.22) 25.43 (14.32–45.16)
AA
No. of cases/total no. of subjects 5/11 23/41 42/55
Odds ratio (95% CI) 20.24 (5.51–74.38) 31.03 (13.72–70.19) 78.46 (34.55–178.17)
* Persons who were homozygous for the low-risk allele (GG) constituted the reference category. Numbers of cases and 
total numbers of subjects are from the joint analysis. OR denotes odds ratio.
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antigen in idiopathic membranous nephropathy8 
(P = 8.6×10−29) (Table 8 and Fig. 12 in the Supple-
mentary Appendix). Subsequent reanalysis with 
the addition of 823 publicly available white Hap-
Map controls increased the significance of the as-
sociation with HLA-DQA1 (P = 1.8×10−116), where-
as the significance of the association with PLA2R1 
was decreased (P = 3.7×10−19) (Fig. 13 in the Sup-
plementary Appendix). This additional finding 
points to the uniqueness of the observed HLA-
DQA1 association in white patients with idiopath-
ic membranous nephropathy. There was no evi-
dence of significant genetic associations with 
SNPs at other genetic loci.
Next we evaluated the effect of the combination 
of risk alleles at the two loci on the risk of idio-
pathic membranous nephropathy. The odds ratio 
for being homozygous for the risk allele in HLA-
DQA1 was 20.2 (95% confidence interval [CI], 5.5 
to 74.4), and the odds ratio for being homozygous 
for the risk allele in PLA2R1 was 4.2 (95% CI, 2.4 
to 7.5). As compared with the odds ratio for ho-
mozygosity for the protective allele at both loci, 
the odds ratio increased, in an additive fashion, 
with each additional copy of the risk allele at 
either locus and was 78.5 (95% CI, 34.6 to 178.2) 
for homozygosity for the risk alleles at both 
rs2187668 (chromosome 6, HLA-DQA1) and 
rs4664308 (chromosome 2, PLA2R1) (Table 3).
The SNP with the overall lowest P value 
(rs2187668) is located within the first intron of 
HLA-DQA1. HLA-DQA1 is an HLA class II alpha-
chain paralogue gene (exon 1 encodes the leader 
peptide, exons 2 and 3 encode the two extracellu-
lar domains, exon 4 encodes the transmembrane 
domain and the cytoplasmic tail, and exon 5 is 
noncoding) that spans 6246 bp of genomic DNA 
on chromosome 6p21 and codes for a 255-ami-
no-acid protein.
The SNP with the smallest P value on chromo-
some 2q24 (rs4664308) lies within the first intron 
of PLA2R1, the gene that encodes the phospho-
lipase A2 receptor 1 isoform 1. The gene spans 
121,110 bp of genomic sequence and contains 
30 exons (all of them coding). The PLA2R1 pro-
tein has 1463 amino acids, with a single-pass 
transmembrane alpha-helix domain, and is a re-
ceptor for secretory phospholipase A2.21 Of note, 
rs4664308 is correlated with rs3749117 (r2 = 0.70), 
encoding a nonsynonymous amino acid substitu-
tion in the extracellular C-type lectin domain 1 of 
PLA2R1, M292V (Table 10 and Fig. 14 in the Sup-
plementary Appendix). The finding that other sig-
nificantly associated SNPs within this gene are 
not correlated or are only weakly correlated with 
rs4664308 provides circumstantial evidence for 
involvement of more than one risk allele in 
PLA2R1 in idiopathic membranous nephropathy 
(Fig. 14 in the Supplementary Appendix). At pres-
ent, 729 SNPs within the genomic region of 
PLA2R1 are known (Table 11 in the Supplemen-
tary Appendix).
Discussion
The association of HLA with idiopathic membra-
nous nephropathy has been shown serologically 
and through molecular typing,22 particularly with 
HLA-DR alleles in whites,23-27 and our study de-
fines this association in detail. We hypothesized 
that patients with idiopathic membranous ne-
phropathy would have distinct similarities in the 
genetic makeup of their immune system best re-
vealed with the use of current technology. Since 
idiopathic membranous nephropathy is a rare dis-
ease (with an estimated incidence of about 1 case 
per 100,000 persons per year), we further hypoth-
esized that the disease would be reflected by al-
leles. In a given population such alleles should be 
recognizable with the use of current SNP chip 
technology and data analyses through classic ge-
Figure 1 (facing page). Manhattan Plots for Genome-
wide Association Studies of Idiopathic Membranous 
Nephropathy (IMN) in Three Groups of Patients and 
Racially Matched Controls.
The red horizontal lines indicate the genomewide sig-
nificance level for the basic allele test, with the use  
of the chi-square test and the Bonferroni correction, 
with adjustment for the genomic inflation factor 
(P<8.5×10−8). Panel A shows the plot for 75 French pa-
tients with idiopathic membranous nephropathy and 
157 racially matched controls, with the use of 315,049 
single-nucleotide polymorphisms (SNPs). The genomic 
inflation factor was 1.02. The most significant associa-
tion is with an allele on chromosome 6 (containing 
HLA-DQA1). Panel B shows the plot for 146 Dutch pa-
tients and 1832 controls, with the use of 282,440 
SNPs. The genomic inflation factor was 1.12. There are 
significant associations with alleles on chromosome 6 
(containing HLA-DQA1) and on chromosome 2 (con-
taining PLA2R1). Panel C shows the plot for 335 British 
patients and 349 control subjects, with the use of 
281,009 SNPs. The genomic inflation factor was 1.15. 
There are significant associations with alleles on chro-
mosome 6 (containing HLA-DQA1) and on chromo-
some 2 (containing PLA2R1).
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Figure 2. Manhattan Plots for the Joint Genomewid  Association Study.
The joint analysis, which included 556 white patients with idiopathic membranous nephropathy and 2338 racially 
matched controls, used 242,824 single-nucleotide polymorphisms (SNPs). Panel A shows the genomewide signifi-
cance level (red horizontal line) for the basic allele test, with the use of the chi-square test and the Bonferroni cor-
rection and with adjustment for the genomic inflation factor (P<8.5×10−8). The inset shows the quantile–quantile 
plot for observed versus expected –log10 P values with and without the extended HLA complex. There are highly sig-
nificant associations with an allele on chromosome 6 (containing HLA-DQA1) and an allele on chromosome 2 (con-
taining PLA2R1). Panel B shows the genomewide significance level (red horizontal line) for the haplotype associa-
tion test with the use of the same data set. MHC denotes major histocompatibility complex.
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nomewide association studies, which use com-
mon SNPs to map common risk variants as well 
as rare risk variants contained in common haplo-
types. Our study shows that a relatively small 
number of cases is sufficient to establish signifi-
cant findings for idiopathic membranous nephrop-
athy in a given population (i.e., associations with 
HLA-DQA1 and PLA2R1 alleles).
The data from the 75 French cases of idio-
pathic membranous nephropathy were sufficient 
to locate a significant association with an HLA-
DQA1 allele. The data from the 146 Dutch cases 
were sufficient to establish significant associa-
tions with both HLA-DQA1 and PLA2R1 alleles. 
The findings in the 335 British cases corrobo-
rated the associations with the HLA-DQA1 and 
PLA2R1 alleles.
Differences between these findings and pre-
viously reported HLA associations are probably 
due to the progress in HLA typing technology 
— that is, the ability to define alleles at a much 
higher resolution within genes and to discrimi-
nate more precisely within the HLA locus. In fact, 
HLA-DQA1 is currently not part of any routine 
HLA typing procedure for renal transplantation 
in the United Kingdom.
The description of these genetic associations 
has important implications. First, our data point 
to the possibility that sequence variations within 
HLA and PLA2R1 are responsible in part for the 
development of idiopathic membranous nephrop-
athy in whites. Second, by adding genetic informa-
tion in an unbiased manner, we provide support 
for the finding, reported by Beck and colleagues, 
that PLA2R1 is associated with idiopathic mem-
branous nephropathy.8 However, our study shows 
a stronger association with HLA than with 
PLA2R1. Thus, it appears that the risk of idio-
pathic membranous nephropathy is higher with 
the HLA-DQA1 allele than with the PLA2R1 allele, 
suggesting that the HLA-DQA1 allele might fa-
cilitate autoantibody development targeting not 
only PLA2R1 but also other antigens. Two other 
such autoantigens in idiopathic membranous ne-
phropathy have recently been identified.9 However, 
no SNPs within these genes — that is, AKR1B1 
(chromosome 7q33) and SOD2 (chromosome 
6q25.3) — showed a significant association in our 
three individual or joint genomewide association 
studies of this disease.
In a study in mice, the susceptibility to anti–
glomerular basement membrane disease was 
linked to the A beta–A alpha region, which cor-
responds to the human HLA-DQ region, support-
ing the importance of the HLA-DQA1 allele in 
immune-related glomerular disease.28
Our results show a highly significant associa-
tion between idiopathic membranous nephropa-
thy and risk alleles of HLA-DQA1 and PLA2R1. 
Although these findings do not establish causality, 
they strongly suggest that an interaction between 
genetic variants of immune-system proteins and 
glomerular components form the basis for the 
development of idiopathic membranous nephrop-
athy, establishing a trigger (the immune system), 
a bullet (PLA2R1 autoantibodies), and a target (glo-
merular antigen). However, the causative link be-
tween the presence of the HLA–DQA1 risk allele 
and PLA2R1 autoantibodies remains unknown.
These findings are in agreement with current 
concepts of autoimmune disease: a recent genome-
wide association study of vitiligo established a 
similar trigger-and-target model by identifying 
significant associations with variants in the HLA 
locus (the trigger) and the gene encoding TYR 
(the target), which encodes a well-recognized au-
toantigen in vitiligo.29 Similarly, variants within 
the HLA system appear to confer a predisposi-
tion to immunologic disorders such as alopecia 
areata through an intricate interplay between in-
nate and adaptive immunity.30
The HLA locus, in its expanded form, covers a 
region of about 8 million bases on chromosome 
6p21 and is considered the most complex locus 
in the human genome owing to extensive recom-
binatory events that occurred during evolution. 
Here, we describe 282 significant associations 
with idiopathic membranous nephropathy with-
in HLA and, in particular, HLA-DQA1. Thirty-five 
different alleles in HLA-DQA1 have been docu-
mented (www.ebi.ac.uk/imgt/hla) and associated 
with various immune-related diseases, but so far, 
none have been linked to idiopathic membranous 
nephropathy.31 However, a report on a previous 
study, in which a traditional method was used 
(restriction-fragment–length polymorphism analy-
sis), pointed out that HLA-DQA1 alleles could be 
involved in idiopathic membranous nephropathy.24 
HLA-DQA1 is part of a heterodimer consisting 
of an alpha chain (DQA) and a beta chain (DQB), 
both anchored in the membrane and forming the 
antigen-presenting groove. This heterodimer plays 
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a central role in the immune system by present-
ing epitope peptides (9 to 15 amino acids in 
length) derived from extracellular antigenic pro-
teins, which in idiopathic membranous ne-
phropathy could, for example, be composed of 
extracellular PLA2R1 fragments (i.e., an epitope 
containing the M292V variant in the C-type lectin 
domain 1). Class II molecules are expressed in 
antigen-presenting cells (e.g., B lymphocytes, den-
dritic cells, and macrophages). Within this class II 
molecule, both the alpha chain and the beta chain 
contain polymorphisms that determine peptide 
binding specificities. Sequence variants in HLA-
DQA1 could therefore change its conformation 
and consequently control the shape of the peptide 
groove, altering the specificity of immunogen pre-
sentation,32,33 although we cannot exclude the 
possibility that a causal variant underlying this 
association is located in one of the neighboring 
genes.
Our findings may also support an additional 
concept concerning the mechanism of autoanti-
body formation. PLA2R1 encodes a protein that 
probably exists in both a transmembrane form and 
a soluble form. The transmembrane receptor may 
increase in the clearance of phospholipase A2, 
thereby inhibiting its action. PLA2R1 is present 
in normal podocytes and in immune deposits in 
patients with idiopathic membranous nephropa-
thy. Sequence variations in PLA2R1 that are related 
to idiopathic membranous nephropathy could con-
trol the pattern of antigen-peptide processing 
through conformational change.34 For example, 
it is conceivable that the amino acid substitution 
M292V encoded by SNP rs3749117 could lead to 
a conformational change in PLA2R1, resulting in 
its functioning as an antigen; there is precedence 
for such a scenario.35 Furthermore, this or other 
sulfhydryl groups on the extracytoplasmic do-
mains within this molecule could be modified 
owing to environmental, accidental, or therapy-
related exposure to heavy metals (e.g., gold or 
mercury), a known cause of secondary membra-
nous nephropathy.36-39
We speculate that sequence variants within 
HLA-DQA1 alleles that are unique to idiopathic 
membranous nephropathy lead to the presentation 
of such peptides to immunocompetent cells, re-
sulting in autoantibody formation. Thus, the co-
existence of risk alleles in HLA and PLA2R1 in the 
same person may circumvent the tightly regulated 
adaptive immune system and allow for the devel-
opment of idiopathic membranous nephropathy. 
Indeed, for persons who are homozygous for the 
risk alleles of both variants, the odds ratio for hav-
ing this disease is almost 80, with additive in-
creases in the odds ratio, depending on the com-
bination of genotypes.
In persons of white ancestry, idiopathic mem-
branous nephropathy is strongly associated with 
risk alleles within the HLA locus in general and 
with HLA-DQA1 in particular, as well as with 
PLA2R1 alleles on chromosome 2. Among the 556 
patients with idiopathic membranous nephropa-
thy in our study, no other autosomal allele was 
significantly associated with this disease. Future 
studies are needed to determine whether the ob-
served whole-genome associations are caused by 
a combination of our identified common variants 
(i.e., SNPs used for genomewide association stud-
ies), by rare genetic sequence variations within 
either the coding or noncoding regions of HLA-
DQA1 and PLA2R1 that are in linkage disequilib-
rium, or by both factors. Studies to assess se-
quence variations in the HLA-DQA1 and PLA2R1 
regions may therefore facilitate the diagnosis of 
idiopathic membranous nephropathy and improve 
our understanding of its pathophysiology.40 Our 
results are consistent with the idea that the an-
tibody response in this disease is related to the 
presentation of a “risk” PLA2R1 epitope by an “id-
iopathic membranous nephropathy” HLA-DQA1 
allele. Antigen presentation may depend on the 
presence of PLA2R1 on dendritic cells or macro-
phages, and podocytes may be an innocent by-
stander. Our findings provide a basis for more 
in-depth research into the role of the immune 
system and PLA2R1 in idiopathic membranous 
nephropathy.
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